Abstract
A severe dose dependent cardiomyopathy is the major limiting factor in the prolonged use of Adriamycin. It has been found to occur in 30% of patients receiving a total cummulative dose of more than 550 mg/M2 body surface area.
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1978 American Institute of Ultrasound in Medicine and Plenum Press, New York
About this chapter
Cite this chapter
Meyer, R.A., Korfhagen, J., Wong, K.Y., Kaplan, S. (1978). Echocardiographic Evaluation of Adriamycin Cardiomyopathy in Children. In: White, D., Lyons, E.A. (eds) Ultrasound in Medicine. Springer, Boston, MA. https://doi.org/10.1007/978-1-4613-4021-8_16
Download citation
DOI: https://doi.org/10.1007/978-1-4613-4021-8_16
Publisher Name: Springer, Boston, MA
Print ISBN: 978-1-4613-4023-2
Online ISBN: 978-1-4613-4021-8
eBook Packages: Springer Book Archive